Rubius Therapeutics, Inc. RUBY NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

Il y a eu 50 transactions d'initiés récentes enregistrées pour Rubius Therapeutics, Inc. (RUBY), dont 32 achats et 15 ventes. Le total des achats d'initiés s'élève à $7.01M et le total des ventes d'initiés à $2.46M.

Les initiés notables ayant une activité récente comprennent Appelhans Dannielle, Cagnoni Pablo J, Turka Laurence A.. Les transactions d'initiés peuvent fournir des indications sur la façon dont la direction perçoit la valorisation et les perspectives futures de l'action.

Transactions d'Initiés — RUBY

Date	Nom	Rôle	Type de Transaction	Actions	Prix Moyen	Valeur	Actions détenues
2023-02-24	Appelhans Dannielle	CEO and President	Vente Informative	10,385	$0.13	$1.32K	-
2023-02-01	Cagnoni Pablo J	Director	Vente Informative	8,448	$0.25	$2.11K	66,082
2023-02-01	Appelhans Dannielle	CEO and President	Vente Informative	3,878	$0.25	$969.50	10,385
2023-01-31	Cagnoni Pablo J	Director	Vente Informative	7,240	$0.24	$1.74K	74,530
2023-01-31	Turka Laurence A.	Chief Scientific Officer	Vente Informative	2,593	$0.24	$622.32	18,391
2023-01-31	Appelhans Dannielle	CEO and President	Exercice d'Options	7,500	-	-	14,263
2023-01-29	Cagnoni Pablo J	Director	Exercice d'Options (Vente)	21,250	-	-	42,500
2023-01-29	Turka Laurence A.	Chief Scientific Officer	Exercice d'Options	7,438	-	-	12,359
2022-08-09	Appelhans Dannielle	Chief Operating Officer	Vente Informative	5,737	$0.80	$4.59K	6,763
2022-07-29	Schaffert Susanne	Director	Attribution de RSU	50,000	-	-	50,000
2022-07-12	Schaffert Susanne	Director	Inconnu	-	-	-	-
2022-05-12	Afeyan Noubar	10 Percent Owner	Attribution de RSU	25,000	$1.24	$31K	25,000
2022-05-12	Epstein David R	Director	Attribution de RSU	499,762	-	-	499,762
2022-05-12	Rosenblatt Michael	Director	Attribution de RSU	25,000	$1.24	$31K	25,000
2022-05-12	Cuss Francis M	Director	Attribution de RSU	25,000	$1.24	$31K	25,000
2022-05-12	Sohn Catherine A.	Director	Attribution de RSU	25,000	$1.24	$31K	25,000
2022-05-12	Holles Natalie C.	Director	Attribution de RSU	25,000	$1.24	$31K	25,000
2022-05-12	Symonds Jonathan	Director	Attribution de RSU	25,000	$1.24	$31K	25,000
2022-05-12	Prener Anne	Director	Attribution de RSU	25,000	$1.24	$31K	25,000
2022-04-21	Epstein David R	Director	Achat Informatif	30,000	$1.44	$43.33K	4,720,012
2022-02-01	Cagnoni Pablo J	CEO and President	Vente Informative	6,730	$6.57	$44.24K	35,520
2022-02-01	Keson-brookes Maiken	CLO & Corp. Secretary	Vente Informative	2,732	$6.57	$17.96K	5,343
2022-02-01	Turka Laurence A.	Chief Scientific Officer	Vente Informative	2,517	$6.57	$16.54K	4,921
2022-01-31	Cagnoni Pablo J	CEO and President	Attribution de RSU	100,000	-	-	100,000
2022-01-31	Carmona Jose	Chief Financial Officer	Attribution de RSU	34,500	-	-	34,500
2022-01-31	Keson-brookes Maiken	CLO & Corp. Secretary	Attribution de RSU	34,500	-	-	34,500
2022-01-31	Turka Laurence A.	Chief Scientific Officer	Attribution de RSU	34,500	-	-	34,500
2022-01-31	Appelhans Dannielle	Chief Operating Officer	Attribution de RSU	30,000	-	-	30,000
2022-01-29	Cagnoni Pablo J	CEO and President	Exercice d'Options	21,250	-	-	42,250
2022-01-29	Keson-brookes Maiken	CLO & Corp. Secretary	Exercice d'Options	8,075	-	-	8,075
2022-01-29	Turka Laurence A.	Chief Scientific Officer	Exercice d'Options	7,438	-	-	7,438
2021-12-31	Cagnoni Pablo J	CEO and President	Inconnu	-	-	-	-
2021-08-31	Appelhans Dannielle	Chief Operating Officer	Attribution de RSU	50,000	-	-	50,000
2021-08-09	Appelhans Dannielle	Officer	Inconnu	-	-	-	-
2021-05-12	Afeyan Noubar	10 Percent Owner	Attribution de RSU	25,000	$23.25	$581.25K	25,000
2021-05-12	Epstein David R	Director	Attribution de RSU	27,919	$23.25	$649.12K	27,919
2021-05-12	Rosenblatt Michael	Director	Attribution de RSU	25,000	$23.25	$581.25K	25,000
2021-05-12	Cuss Francis M	Director	Attribution de RSU	25,000	$23.25	$581.25K	25,000
2021-05-12	Sohn Catherine A.	Director	Attribution de RSU	25,000	$23.25	$581.25K	25,000
2021-05-12	Holles Natalie C.	Director	Attribution de RSU	25,000	$23.25	$581.25K	25,000
2021-05-12	Symonds Jonathan	Director	Attribution de RSU	25,000	$23.25	$581.25K	25,000
2021-05-12	Prener Anne	Director	Attribution de RSU	25,000	$23.25	$581.25K	25,000
2021-03-19	Flagship Ventures Fund Iv General Partner Llc	10 Percent Owner	Achat Informatif	70,000	$29.00	$2.03M	2,633,703
2021-03-15	Keson-brookes Maiken	CLO & Corp. Secretary	Vente Informative	25,000	$20.24	$505.97K	-
2021-02-11	Epstein David R	Director	Vente Informative	26,704	$14.93	$398.56K	4,690,012
2021-02-10	Epstein David R	Director	Vente Informative	7,404	$14.79	$109.53K	4,716,716
2021-02-09	Epstein David R	Director	Vente Informative	2,100	$14.83	$31.15K	4,724,120
2021-02-08	Epstein David R	Director	Vente Informative	89,233	$14.88	$1.33M	4,726,220
2021-01-29	Cagnoni Pablo J	CEO and President	Attribution de RSU	85,000	-	-	85,000
2021-01-29	Keson-brookes Maiken	CLO & Corp. Secretary	Attribution de RSU	32,300	-	-	32,300

■ Informatif — transaction sur marché ouvert (la plus significative) ■ Non informatif (achat) — récompense, exercice d'option, conversion ■ Non informatif (vente) — retenue fiscale, vente à l'acquisition ■ Neutre — don, fiducie, expiration